Related Experiment Video
Updated: Feb 22, 2026

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
Allosteric modulators targeting CNS muscarinic receptors
Andreas Bock1, Ramona Schrage2, Klaus Mohr2
1Max Delbrück Center for Molecular Medicine, Robert-Rössle-Strasse 10, 13125 Berlin, Germany; Institute of Pharmacology and Toxicology, University of Würzburg, Versbacher Strasse 9, 97078 Würzburg, Germany.
Allosteric modulators offer precise control over muscarinic receptors, crucial drug targets for neurological diseases. Their mechanisms are broadly applicable to other G protein-coupled receptors (GPCRs).
Area of Science:
- Neuropharmacology
- Molecular Biology
- Drug Discovery
Background:
- Muscarinic acetylcholine receptors (GPCRs) are vital drug targets for CNS disorders like Alzheimer's and Parkinson's.
- Five subtypes (M1-M5) exist, with M1-M4 structures elucidated, all featuring allosteric binding sites.
- Allosteric sites, located extracellularly, allow specific modulation of receptor activity.
Purpose of the Study:
- To review the principles of allosteric modulation for GPCRs, focusing on muscarinic receptors.
- To discuss dualsteric ligands and their potential in modulating muscarinic receptor dynamics and signaling.
- To highlight the generalizability of muscarinic receptor allosteric modulation mechanisms to other GPCRs.
Main Methods:
- Review of existing literature on muscarinic receptor allosteric modulation.
- Analysis of molecular and structural principles of GPCR allosteric modulation.
- Discussion of dualsteric (bitopic) ligand mechanisms and potential.
Main Results:
- Allosteric modulators provide specific control over muscarinic receptor affinity and efficacy.
- Dualsteric ligands offer unique ways to modulate receptor dynamics and signaling pathways.
- Mechanisms of muscarinic receptor allosteric modulation are applicable across the GPCR superfamily.
Conclusions:
- Allosteric modulation represents a powerful strategy for selective GPCR targeting in drug discovery.
- Muscarinic receptors serve as a paradigm for understanding and developing allosteric modulators for various GPCRs.
- Further research into muscarinic allosteric modulation can advance treatments for neurological and other diseases.
More Related Videos
07:09Subcutaneous Administration of Muscarinic Antagonists and Triple-Immunostaining of the Levator Auris Longus Muscle in Mice
Published on: September 8, 2011
07:02A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
Published on: February 11, 2019
Related Concept Videos
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
The direct-acting...
Cholinergic Receptors: Muscarinic
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+....
Direct-Acting Cholinergic Agonists: Pharmacological Actions
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
Direct-Acting Cholinergic Agonists: Pharmacokinetics
Cholinergic Antagonists: Pharmacological Actions
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...